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Ethylene glycol ingestion results initially in CNS effects. After a characteristic latent 
period, signs of inebriation may be followed by serious illness, and even death, 
caused by toxic metabolites.
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compounds that are normal constituents of the citric acid cycle.
No health effects have been reported in persons chronically exposed to levels of  
ethylene or propylene glycol found in the environment.
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education units.
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How to use this issue...
This issue begins with a composite case study that describes a realistic encounter with a patient. This description 
is followed by a pretest. The case study is further developed through Challenge questions at the end of each 
section. To fully benefit from this monograph, readers are urged to answer each question when it is presented. 
(Answers to the Pretest and Challenge questions are found on pages 21 -22.) The monograph ends with a posttest, 
which can be submitted to the Agency for Toxic Substances and Disease Registry (ATSDR) for continuing medical 
education (CME) credit or continuing education units (CEU). See page 23 for further instructions on howto receive 
these credits.
The objectives of this monograph on ethylene glycol and propylene glycol are to help you
□  Explain why ethylene glycol may be an acute and chronic health hazard
□  Describe the factors contributing to glycol toxicity
□  Identify potential environmental and occupational sources of exposure to glycols
□  Identify evaluation and treatment protocols for persons exposed to glycols
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Case Study
Disorientation, ataxia, and abdominal symptoms in visitors to a municipal airport
A 67-year-old man is brought to the Emergency Department (ED) of a small community hospital where you are 
the family physician on call. The patient is experiencing ataxia, dizziness, and vomiting. He is hyperventilating. On 
physical examination, the patient appears well nourished, agitated, and disoriented. There is no odor of ethanol on 
his breath. His vital signs include blood pressure, 120/80 mm Hg; temperature, 98.5”F; pulse, 80 beats/minute; and 
respirations, 40 breaths/minute. Neurologic examination is normal, and there is no nystagmus. Abdominal and 
cardiorespiratory examinations are also normal.
The patient was brought to the ED by his friend, who relates that the patient said he felt dizzy and began vomiting 
late last night. This morning he was hyperventilating and continued to vomit. Both men are retired pilots who teach 
at the ground school at the local airport. Because two other people had collapsed at the airport that morning and were 
taken by ambulance to another hospital, the friend wonders if the food at the airport cafeteria is responsible. Both 
he and the patient had hot dogs and coleslaw; yet the friend states that he feels fine.
Although the friend insists that the patient drank only water all day, you order a blood ethanol level, as well as a 
drug screen, arterial blood gases (ABG), serum electrolytes, BUN, creatinine, and glucose. Blood ethanol and drug 
screen are negative, and ABG results reveal pH 7.10; Paco21 20 mm Hg; and Pao2 95 mm Hg. Other test results are 
sodium, 145 mEq/L; potassium, 3.8 mEq/L; chloride, 105 mEq/L; bicarbonate, 8 mEq/L; BUN, 20 mg/dL; creatinine,
1.0 mg/dL; and glucose, 80 mg/dL. The calculated anion gap is 32 (normal 12 to 16).
Less than 30 minutes later, a 4-year-old boy is brought to the ED. On examination, you find a sleepy but arousable 
child. There is no evidence of trauma or focal neurologic signs. Abdominal and cardiorespiratory examinations are 
normal. Vital signs include rectal temperature, 97.8T; respirations, 12 breaths/minute; pulse, 78 beats/minute; BP, 
94/76 mm Hg. The parents tell you that they were attending a local fliers’ club luncheon at the airport. When they found 
the child staggering and incoherent, they rushed him to the ED; the child vomited in the car. You order the same 
laboratory tests for the child that you ordered for the 67-year-old patient. From the results of the child’s tests, you note 
that the child is hypoglycemic and slightly acidotic. You calculate an anion gap of 13.
You contact the local health department and are told that they are investigating the earlier incidents at the airport. 
They suspect that the airport’s water supply is contaminated, but they have not identified the contaminant.
iV re te s t-J ^ ^
(a) What would you include in each patient’s problem list? What is the differential diagnosis for an anion gap 
metabolic acidosis?
(b) What additional tests, if any, will you order for these patients?
(c) How will you initially treat these patients?
Answers to the Pretest questions are on page 21.
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Ethylene glycol and propylene glycol are manufactured chemicals 
that have similar physical properties and uses. Their chemical 
structures differ by only one methyl group (ethylene glycol, 
HOCH2CH2OH;propyleneglycol,CH3CH[OH]CH2OH).Both chemi­
cals are clear, colorless, odorless, sweet-tasting, highly viscous 
liquids. They have low vapor pressures at room temperature, 
indicating low potential for inhalation exposure.
Despite similarities in physical properties and chemical structure, 
ethylene glycol and propylene glycol have vastly different toxicities. 
Ethylene glycol is acutely toxic to humans, whereas propylene 
glycol is a safe additive for foods and medications. Propylene glycol 
causes poisoning only rarely and under unusual circumstances. 
These glycols should not be confused with glycol ethers (e.g., 
ethylene glycol monomethyl ether, also known as methyl cellosolve, 
and ethylene glycol monoethyl ether), which are suspected repro­
ductive and developmental toxicants. A discussion of ethylene 
glycol follows; discussion of propylene glycol begins on page 18.
Ethylene Glycol
Exposure Pathways __
Ethylene glycol is used in many industries because it has the ability 
to absorb water and to prevent overheating or freezing. It is used 
extensively in automotive fluids such as antifreeze, coolants, and 
hydraulic fluids. Antifreeze, which typically consists of 95% ethyl­
ene glycol, accounts for about 65% of the ethylene glycol produced. 
Ethylene glycol is also used in cosmetics, fat extractants, and as a 
chemical intermediate. As a solvent, it is found in inks, stains, 
pesticides, fire extinguishers, foams, polishes, and adhesives. Its 
heat-regulation properties are employed in air conditioning units 
and solar energy systems.
Synonyms for ethylene glycol include ethylene alcohol, glycol 
alcohol, glycol, 1,2-dihydroxyethane, and 1,2-ethanediol. Com­
mercial products containing high concentrations of ethylene glycol 
include Dowtherm SR1*, Lutrol-9, Norkool, Tescol, and UCAR-17.
Waste streams produced when ethylene glycol is manufactured or 
used account forthe mostsignificant releases of this compound into
* Use of trade names is for identification only and does not imply endorse­
ment by the Public Health Service or the U.S. Department of Health and 
Human Services.
□  Antifreeze, which can contain 
up to 95% ethylene glycol, is 




the environment. In military and commercial aviation, large amounts 
of ethylene glycol are used for deicing. It is sprayed as an aerosol 
or mist onto airplane wings to prevent ice buildup. Used in this 
manner, ethylene glycol can contaminate groundwater near air­
ports through runoff and may expose workers to air levels ranging 
from <0.05 milligrams per cubic meter (mg/m3) to 10.4 mg/m3(i.e., 
<0.02 parts per million [ppm] to 4.2 ppm). The Occupational Safety 
and Health Administration (OSHA) ceiling limit (15-minute sample) 
for ethylene glycol is 125 mg/m3 or 50 ppm. Ethylene glycol is also 
used in coolant loops in spacecraft and in aviator protective clothing; 
both applications present potential for exposure if leaks occur.
Ethylene glycol does not persist in ambient air in large amounts 
because breakdown is rapid (half-life in air is 24 to 50 hours). Its low 
vapor pressure precludes substantial inhalation exposure at ambi­
ent temperatures, and its poor skin absorption prevents significant 
absorption after dermal contact. Ethylene glycol is miscible with 
water and adheres to soil (half-life in water and soil is several days). 
Because it is not fat-soluble, bioconcentration and bioaccumulation 
are insignificant.
Because of its low vapor 
pressure and poor skin 
absorption, ethylene glycol 
poisonings normally occur 
by ingestion.
Ethylene glycol rapidly 
degrades in the environment.
ChaCCeng\
(1 ) What questions would health department investigators ask airport visitors and employees to establish 
the exposure source?
Who's at Risk
Workers in industries that manufacture Or use products containing 
ethylene glycol, particularly operations involving automobile main­
tenance and aircraft deicing, are at greatest risk of exposure. 
Although dermal contact is the main route of occupational exposure, 
vapors or mists can be inhaled when the chemical is heated, 
agitated, or sprayed.
Workers in industries 
producing or using products 
that contain ethylene glycol 




□  The general population has 
risk of exposure to ethylene 
glycol primarily through 
contact with automobile 
antifreezes and coolants.
Biologic Fate
□  Absorption of ethylene glycol 
by the gastrointestinal tract is 
rapid; dermal absorption is 
slow. Inhalation is not an 
important route of exposure 
under normal conditions of 
use.
□  Ethylene glycol is
metabolized in the liver to a 
variety of more toxic 
compounds.
□  Only a small fraction of 
absorbed ethylene glycol is 
normally excreted 
unchanged in the urine.
There have been no reports of adverse health effects from chronic 
environmental exposures to ethylene glycol, and few data exist to 
evaluate such effects from these exposure scenarios. In the general 
population, ethylene glycol exposure occurs most commonly through 
accidental or intentional ingestion of antifreeze. During 1990,3,242 
cases of ethylene glycol exposure were reported to the 72 poison 
centers participating in the National Data Collection System of the 
American Association of Poison Control Centers. Of these, 1,451 
patients (45%) were examined in health care facilities, 1,147 (35%) 
became symptomatic, 62 (2%) developed major symptoms, and 5 
(0.2%) died. The remainder (577[17.8%]) suffered no ill effects. The 
general population can also be exposed to ethylene glycol by dermal 
contact while handling automotive antifreezes, coolants, and brake 
fluids; however, such exposure is not likely to cause adverse health 
effects under normal conditions.
Ethylene glycol is rapidly absorbed by the gastrointestinal tract, less 
rapidly by the lungs, and slowly through the skin. Because of 
ethylene glycol’s low vapor pressure, inhalation is generally not 
associated with toxicity, although neurologic symptoms including 
nystagmus and syncope were reported in factory workers chroni­
cally exposed to vapor from heated ethylene glycol.
Because it is highly water-soluble, ethylene glycol is evenly distrib­
uted throughout the body. It reaches peak tissue levels 1 to 4 hours 
after ingestion. Approximately 24 hours later, no unchanged 
ethylene glycol is detected in urine or tissues, indicating rapid 
biotransformation. The normal serum half-life of ethylene glycol is 
approximately 2.5 hours.
Although ethylene glycol itself has relatively low toxicity, it is me­
tabolized in the liver to a variety of toxic compounds (Figure 1), some 
of which have elimination half-lives of up to 12 hours. The rate- 
limiting step in this metabolic process is the conversion of ethylene 
glycol to glycoaldehyde. Generally, only a small fraction of ethylene 
glycol (Iessthan20%in low-dose ingestions) is excreted unchanged 
in the urine. However, coadministration of ethanol, which inhibits 
ethylene glycol metabolism by preferentially reacting with alcohol 
dehydrogenase, can extend the serum half-life of ethylene glycol to 
17 hours and increase the percentage of ethylene glycol that is 
ultimately excreted unchanged. This mechanism is the basis for the 
antidotal use of ethanol in ethylene glycol-poisoned patients.
Persons who have impaired liver or kidney function, and children, 
who have immature hepatic detoxification systems, may be at greater 
risk of ethylene glycol’s initial central nervous system (CNS) effects. 
However, the clinical courses of illness in such patients may be less 
severe because of decreased abilities to form toxic metabolites.
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Additional information for the case study: The health department identifies the water contaminant as 
ethylene glycol. When construction crews at the airport were repairing the water supply system, they 
inadvertently connected the water from the heating system to the drinking water system. The concentra­
tion of ethylene glycol measured at the cafeteria’s water source was 9%, or 90,000 ppm. The 
Environmental Protection Agency (EPA) has a drinking water quality guideline of 7 ppm for ethylene 
glycol. The lethal dose of 95% ethylene glycol is about 100 mL.
(2) Who in the case study may be at risk of adverse health effects? Explain.
Physiologic Effects
Neurobehavioral Effects
□  Unmetabolized ethylene 
glycol contributes to CNS 
depression.
The aldehyde metabolites of ethylene glycol are the cause of many 
of ethylene glycol’s delayed toxic effects. These metabolites inhibit 
oxidative phosphorylation; cellular respiration; and glucose, pro­
tein, andserotonin metabolism. In addition, accumulation of glycolic 
acid, glyoxylic acid, and, to a lesser extent, oxalic acid, results in 
metabolic acidosis. (Lactic acid formed during the metabolism of 
ethylene glycol to oxalic acid also contributes to the metabolic 
acidosis in patients poisoned by this glycol.)
□  Delayed clinical toxicity 
results from the conversion 
of ethylene glycol to more 
toxic metabolites.
Ethylene glycol poisoning typically has three phases (Table 1). 
Phase 1, which begins 30 minutes to 12 hours after ingestion, 
includes signs of inebriation and CNS depression from unmetabolized 
ethylene glycol and from aldehyde metabolites that peak 6 to 12 
hours after ingestion. In some cases, cerebral edema develops. 
Signs of metabolic acidosis may become apparent late in Phase 1.
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Affected Signs and Symptoms




Ataxia, nystagmus, coma, 
myoclonus, seizures
Nausea, vomiting
2 12 to 24 hours Cardiovascular
Pulmonary
Metabolic
Mild hypertension, tachycardia, shock
Tachypnea, adult respiratory distress syndrome, 
pulmonary edema, pneumonitis
Metabolic acidosis with elevated anion and osmolal gaps, 
possible tetany from hypocalcemia, and hyperventilation
3 24 to 72 hours Renal Flank pain, costovertebral angle tenderness, oliguric 
renal failure, hyperkalemia
Phase 2, the cardiopulmonary toxicity phase, begins 12 to 24 hours 
after ingestion. Deposition of calcium oxalate crystals can cause 
tissue injury in various sites including the meninges of the brain, 
vascular tree, myocardium, and lung parenchyma. Hypocalcemia 
may occur secondary to the precipitation of calcium by the oxalate 
metabolite.
Phase 3, which begins 24 to 72 hours after ingestion, can be 
manifested by a profound metabolic acidosis. Deposition of calcium 
oxalate crystals in the kidneys can lead to acute renal failure (irrevers­
ible in some cases) and hyperkalemia.
The minimum lethal ingested dose of antifreeze (95% ethylene 
glycol) for adults is approximately 1.4 mL/kg body weight or about 
100 mL of antifreeze for a 70-kg person, although persons who 
attempted suicide by ingesting 1 to 2 liters of the 95% solution and 
were treated within 1 hour have survived.
Neurologic Effects
The initial phase of ethylene glycol poisoning is characterized by 
inebriation caused by unmetabolized ethylene glycol. In acute poi­
soning, ataxia, slurred speech, and somnolence are common, as are 
irritation, restlessness, and disorientation. Cerebral edema and crys­
talline deposits of calcium oxalate in the walls of small blood vessels 
in the brain may increase CNS depression. In severe poisonings, 
myoclonic jerks, convulsions, and coma can occur.
□  Signs of inebriation are 
among the first to appear 
after ethylene glycol 
ingestion. Any delay in 
initiating supportive and 
specific treatment may 




□  Ingestion of ethylene glycol 
can cause noncardiogenic 
pulmonary edema.
□  Ethylene glycol ingestion can 
produce conduction 
disturbances and cardiac 
dysrhythmias.
□  Patients who have ethylene 
glycol poisoning 
characteristically 
have an elevated anion gap 
and osmolal gap.
Several case reports of acute ethylene glycol poisoning have 
described effects on cranial nerves (e.g., facial paralysis, hearing 
loss, and bilateral visual disturbances) that occurred 5 or more days 
after ingestion. These sequelae, however, are not seen often; delay 
in instituting treatment may contribute to their development.
Respiratory Effects
Pulmonary effects typically occur 12 to 72 hours after ingestion and 
may include hyperventilation, respiratory distress syndrome, 
pneumonitis, and noncardiogenic pulmonary edema. Oxalate crys­
tals in lung parenchyma have been found at autopsy in some 
ethylene glycol-poisoned patients.
In one study, volunteers who inhaled aerosolized ethylene glycol at 
a mean concentration of 31 mg/m3(12.4 ppm) for 20 to 22 hours per 
day for 4 weeks experienced throat and upper respiratory-tract 
irritation. Potential for long-term exposure to ethylene glycol exists 
in spacecraft if cooling systems leak.
Cardiovascular Effects
Cardiovascular effects occur most often in conjunction with respira­
tory compromise. Deposition of calcium oxalate crystals in the 
vascular tree and in cardiac tissue may cause the mild hypertension 
or hypotension and dysrhythmias experienced by patients severely 
poisoned with ethylene glycol.
Metabolic Effects
If large doses of ethylene glycol are ingested, poisoning is accom­
panied by metabolic acidosis, with onset occurring within 24 hours 
after ingestion. This acidosis is caused primarily by the accumula­
tion of glycolic and glyoxylic acids, although oxalic acid and excess 
lactic acid may be contributing factors. These acidic metabolites 
release hydrogen ions, which react with bicarbonate, decreasing 
the pH in serum and other body fluids. An elevated anion gap results. 
In addition, ethylene glycol is osmotically active, thereby causing an 
increased measured osmolal gap. (Osmolality is the osmotic con­
centration, defined as the moles of solute divided by the number of 
particles into which it dissociates per kilogram of solvent.)
Tetany can sometimes occur due to hypocalcemia. Hypocalcemia 





Nephrotoxicity manifests about 24 to 72 hours after substantial 
ingestion of ethylene glycol. It results from precipitation of calcium 
oxalate crystals in renal tubules and from the direct cytotoxic action 
of ethylene glycol metabolites (e.g., oxalic and glycolic acids). 
Interstitial changes in the kidney are accompanied by acute tubular 
necrosis. In most cases, the renal injury resolves after recovery; 
however, it can be irreversible.
□  Nephrotoxicity is the 
dominant effect of serious 
ethylene glycol poisoning.
Other Effects
Ethylene glycol is only a minor skin irritant, although a few cases of 
allergic contact dermatitis have been documented. Acute iridocyclitis 
has been reported after accidental eye contact with the liquid.
□  Ethylene glycol is a skin and 
mucous membrane irritant.
No studies in experimental animals have linked ethylene glycol to 
cancer. One epidemiologic study found an elevated odds ratio for 
renal cancer in workers exposed to ethylene glycol; however, these 
workers may have been exposed to other chemicals also.
Studies in experimental animals do not indicate that ethylene glycol 
causes developmental effects. Although studies in humans have not 
specifically addressed effects on the fetus, adverse reproductive or 
developmental outcomes in humans have not been reported.
Data are inadequate to 
determine whether ethylene 
glycol is a carcinogen or a 
reproductive hazard in 
humans.
jé ®ChaCCeng.
(3) A week after the water contamination incident, a patient comes to your office. He deices 
airplanes at the a irport and was involved in a m ajor sp ill yesterday when he was drenched 
with deicing fluid. He knows that deicing agents contain large amounts o f ethylene glycol. 
He imm ediately showered and changed clothes a fte r the incident, but he is worried about 
possible adverse health effects; he wonders if  cancer could develop. What will you tell him?
(4) A pregnant worker at the airport consults you because she drank tea made with the contaminated 
water. Although she consumed only a small amount of tea and had no ill effects, she is worried tha t 




□  A detailed history is important 
in diagnosing ethylene glycol 
poisoning.
□  Prompt recognition and early 
therapeutic intervention are 
essential to preventing latent 
effects and potential sequelae 
of ethylene glycol poisoning.
History and Physical Examination
Ethylene glycol ingestion is a medical emergency requiring prompt 
recognition and aggressive treatment for a good outcome. The 
clinical picture in ethylene glycol poisoning varies based upon the 
amount ingested, the time elapsed since ingestion, and the concur­
rent ingestion of large amounts of ethanol. Making a correct decision 
regarding treatment requires a reliable history of the time, route, and 
magnitude of exposure. However, a detailed history can be difficult 
to obtain because patients often have an altered mental state. If 
ethylene glycol poisoning is strongly suspected, supportive and 
specific treatment should be instituted pending confirmatory labora­
tory results.
Although there is concern about environmental exposures to ethyl­
ene glycol, nearly all cases of ethylene glycol poisoning are due to 
ingestions. A history of alcohol abuse may suggest ingestion of 
ethylene glycol as an ethanol substitute. A meticulous search in the 
home for ethylene glycol-containing compounds should be made in 
all suspected poisonings. If a product label does not list the chemical 
ingredients, the regional poison control center may be able to assist. 
Inquiring about similar symptoms in family members, friends, and 
coworkers may be helpful in identifying a common source of expo­
sure.
The patient’s vital signs should be monitored. Although not specific 
for ethylene glycol intoxication, hypertension, tachycardia, and low- 
grade fever have been associated with moderate or severe poison­
ing. A complete neurologic examination should be performed with 
special attention directed to gait and balance.
Numerous exogenous toxic substances are associated with an 
elevated anion gap (Table 2). Only four conditions will cause meta­
bolic acidosis and elevate both the anion and osmolal gaps—  
methanol poisoning, ethylene glycol poisoning, alcoholic ketoacidosis, 
and diabetic coma. However, when large quantities of ethanol are 
ingested concomitantly with ethylene glycol, enzymatic conversion 
to toxic metabolites that produce metabolic acidosis will be inhibited. 
Inhibiting metabolism also increases the amount of unchanged 
ethylene glycol circulating in the body. Hence, a patient who has 
concomitantly ingested ethanol could have an elevated osmolal gap 
without an elevated anion gap early in the clinical course. The 
presence of metabolic acidosis and either an anion or osmolal gap 
should alert the clinician to the possibility of ethylene glycol poisoning.
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Ethanol + + + + Alcoholic
ketoacidosis
Ethylene glycol + ++
'
+ Renal failure, 




Isopropanol + — ++ + Hemorrhagic 
tracheobronchitis 
and gastritis
Salicylates + + + - Vomiting, tinnitus, 
hyperthermia
Adapted from Goldfrank LR. Goldfrank’s toxicologic emergencies. 4th ed. Norwalk, Connecticut: Appleton and Lange, 1990:483.
Signs and Symptoms
Patients who have ingested ethylene glycol often progress through 
three clinical phases. These phases representa continuum, and an 
individual patient may have any combination of organ or systemic 
effects (Table 1, page 7). The time course for each phase, as well 
as the severity of illness, is dependent on the amount of ethylene 
glycol ingested and whether ethanol was ingested concurrently.
CNS signs and symptoms predominate during the first 12 hours, 
including headache, slurred speech, dizziness, ataxia, myoclonic 
jerks, convulsions, coma, and death. In mild cases, the patient may 
appear inebriated but have no ethanol odor on the breath. Abdomi­
nal pain with nausea and vomiting is common.
Phase 2 begins 12 to 24 hours after ingestion and is caused by the 
products of ethylene glycol metabolism. The primary manifestations 
are cardiopulmonary with tachypnea, tachycardia, dysrhythmias, 
hypertension or hypotension, respiratory distress syndrome, and 
pulmonary edema. Profound metabolic acidosis may be present.
□  Patients with ethylene glycol 
poisoning may initially appear 
inebriated and may lack 
severe toxic manifestations.
□  After a characteristic latent 
period, metabolites of ethylene 




Phase 3 occurs 24 to 72 hours after ingestion if the condition is not 
treated or is treated unsuccessfully. Acute renal dysfunction sec­
ondary to acute tubular or cortical necrosis is seen. Renal dysfunc­
tion varies from mild elevation in BUN to overt oliguric renal failure. 
The renal failure usually resolves but may be irreversible in some 
cases. Myopathy and bone marrow suppression have also been 
reported.
In some cases, facial paralysis and other cranial-nerve abnormali­
ties may occur several days after ingestion. These neurologic 
sequelae are usually found when treatment is delayed or inad­
equate.
Laboratory Tests
An elevated anion-gap 
metabolic acidosis and an 
elevated osmolal gap 
combined with urinary 
crystals suggest ethylene 
glycol poisoning.
Measurement of serum 
ethylene glycol levels can 
confirm poisoning.
The abnormal laboratory findings in ethylene glycol poisoning 
include an elevated anion-gap metabolic acidosis, an increased 
osmolal gap, elevated serum ethylene glycol level, calcium oxalate 
or hippurate crystalluria, and sometimes, hypocalcemia. Arterial 
blood gases, blood glucose, serum electrolytes, and blood ethanol 
should be measured in all patients with histories of ethylene glycol 
ingestion or in whom poisoning is suspected. Results of these 
laboratory tests will confirm the presence and degree of metabolic 
acidosis and allow calculation of the anion and osmolal gaps (Table 
3). A blood ethanol level will establish whether initial CNS symptoms 
are due to ethanol. The presence of ethanol will also have a 
substantial impact on metabolism and therapy.
Table 3. Formulas for calculating anion and osmolal gaps
The serum anion gap (AG) is determined from serum electrolytes measured in mEq/L and may be defined 
by the formula
AG = ( Na++ K+) -  ( Cl- + HCO3- )
(Normal anion gap: 12 to 16)
The serum osmolal gap (OG) is most commonly approximated by the formula
OG = Osmolality (measured). -  2Na+ + [BUN-2.8] + [Glucose+18]
(Normal osmolal gap: <10)
* In this formula, Osrnolality(measured) is obtained by the freezing-point-depression method and expressed in milliosmoles per liter 
(mOsm/L); Na+ in mEq/L; BUN and glucose in mg/dL.
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The presence of calcium oxalate or hippurate crystals in the urine, 
together with an elevated anion gap or osmolal gap, strongly 
suggests ethylene glycol poisoning. Urinary crystals result from the 
precipitation of calcium by the oxalic acid metabolite of ethylene 
glycol or from the reaction of the glycine metabolite with benzoic acid, 
which forms hippuric acid. The crystals can take many forms 
including dumbbells, envelopes, or most commonly, needles. Ab­
sence of urinary crystals, however, does not rule out poisoning. 
Because some antifreeze products contain fluorescein, the urine 
may fluoresce under a Wood’s lamp.
An elevated serum level of ethylene glycol confirms ethylene glycol 
poisoning; significant toxicity is associated with levels greater than 
50 mg/dL. Communication with the laboratory is critical in poisoning 
cases because 2,3-butanediol often found in the plasma of alcohol­
ics can be mistakenly identified as ethylene glycol when the analysis 
is performed by gas chromatography. Furthermore, propylene glycol 
may interfere with some assays for ethylene glycol.
ChaCCeng<
(5) What additional laboratory tests will you order for the man and child described in the case study on 
page 1?
Treatment and Management
Treatment should not be delayed pending results of ethylene glycol 
serum levels if the clinical picture is severe or if the history suggests 
such poisoning. Treatment advice can be obtained from a regional 
poison control center or medical toxicologist.
Initial management of suspected poisoning includes basic life sup­
port with intubation and mechanical ventilation if required. When the 
ingestion is recent, measures to prevent ethylene glycol absorption
Correction of metabolic 
acidosis is an important part of 
treatment in ethylene glycol 
poisoning.
13
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should be taken If the patient’s level of consciousness permits. 
Induced emesis or gastric lavage may be useful if ingestion oc­
curred within 1 to 2 hours. Activated charcoal is not likely to be 
effective because it does not adsorb ethylene glycol well.
□  Specific treatments for Specific treatment for ethylene glycol poisoning consists of sodium
ethylene glycol poisoning are bicarbonate to correct the metabolic acidosis, ethanol to competi-
ethanol therapy and tively inhibit conversion of ethylene glycol to its more toxic metabo-
hemodialysis. ütes ancj hemodialysis to remove ethylene glycol and glycolic acid.
Although this treatment regimen is effective in most cases, renal 
failure and death can occur if treatment is delayed.
Ethanol is used to saturate the alcohol dehydrogenase enzyme so 
that ethylene glycol is maintained in an unmetabolized form and 
excreted unchanged in the urine. Ethanol therapy should be consid­
ered when ethylene glycol levels are greater than 20 mg/dL or when 
ethylene glycol poisoning is strongly suspected. Patients who have 
a history of concurrent ethanol ingestion, or who are undergoing 
hemodialysis, require dosage modification (Table 4). Ethanol can 
cause hypoglycemia, particularly in children; therefore, blood glu­
cose should be monitored closely. The hypoglycemia that develops 
in adults is often overlooked because the impairment of mental 
status is attributed to the ethanol.
Table 4. Intravenous administration of ethanol in ethylene glycol and methanol poisoning
Goal of ethanol therapy: Maintain blood ethanol level between 100 and 150 mg/dL
Loading dose mg/kg mL of 10% ethanol/kg
600 to 800 7.6 to 10
Maintenance dose mg/kg/hr mL of 10% ethanol/kg/hr
Chronic alcoholic 154 1.95
Social drinker 110 1.39
Nondrinker 66 0.83
During hemodialysis* mg/kg/hr mL of 10% ethanol/kg/hr
Chronic alcoholic 304 3.85
Social drinker 256 3.29
Nondrinker 216 2.73
* Assuming no ethanol is added to dialysis bath.
Adapted from Hall AH. Ethylene glycol and methanol: poisons with toxic metabolic activation. Emergency medicine reports 
1992;13(4):29-38.
The loading dose and the maintenance dose should be infused over 
the first hour of therapy. Decrease to only the maintenance dose in 
the second hour. If the drinking habits of a patient cannot be 
determined from the history, assume the patient is in the category 
of “social drinker,” then adjust the dose to achieve a blood ethanol 
level that remains between 100 and 150 mg/dL.
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To prepare 1 liter of 10% ethanol in 5% dextrose in distilled water 
(DSW) for intravenous infusion, perform eitheroi the following steps:
1. Remove 100 mL of fluid from 1 liter of D5W; replace with 100 mL 
of absolute ethanol, or
2. Remove 50 mL of fluid from 1 liter of commercially available 5% 
ethanol in D5W solution; replace with 50 mL of absolute ethanol.
Blood ethanol and serum glucose levels should be monitored at the 
end of the loading dose and hourly until the maintenance dose is 
adjusted. Both should then be monitored two to three times daily, but 
more frequently during dialysis.
Hemodialysis should be considered if serum ethylene glycol levels 
exceed 50 mg/dL, if severe acid/base or fluid/electrolyte distur­
bances persist despite decontamination and ethanol therapy, or if 
renal failure develops. Hemodialysis should be continued until 
acidosis is controlled and the serum ethylene glycol level is in the 
10 to 15 mg/dL range. Ethanol therapy can be discontinued when the 
serum ethylene glycol level is below this range.
Thiamine and pyridoxine, two water-soluble B complex vitamins that 
act as metabolic cofactors, are commonly administered to patients 
who have ethylene glycol toxicity. Pyridoxine is administered intra­
venously (100 mg or 1 mg/kg daily until intoxication is resolved). If the 
vitamins are administered before dialysis, the dose should be 
repeated after dialysis because they are highly water-soluble and 
are likely to be removed by the procedure. Thiamine is administered 
intravenously (100 mg or 1 mg/kg daily) until intoxication is resolved. 
These cofactors help convert ethylene glycol to less toxic metabo­
lites and may decrease the formation of oxalate.
4-Methylpyrazole is a specific inhibitor of the alcohol dehydrogenase 
enzyme. It has low toxicity and may replace ethanol in the treatment 
of ethylene glycol poisoning. At present, 4-methylpyrazole is under­





Additional inform ation for the case study: It was la te r determ ined that during dinner at the 
cafeteria, the 67-year-old man had consumed several cups o f coffee, while his friend, who did 
not become ill, drank only soda from a can. The serum ethylene glycol level for the 67-year- 
old patient is 55 mg/dL; the anion gap is 35.
(6) How will you treat the 67-year-old patient?
Additional inform ation for the case study: The ch ild ’s ethanol level is 85 mg/dL. You repeat the 
ethanol test, and again the result is high. The parents are incredulous but adm it that the child  
was not supervised closely during the luncheon, where wine and cocktails were served. 
Potential ethylene glycol exposure sources for the ch ild  could not be identified.
(7) How will you treat the child?
Standards and Regulations
Workplace
OSHA has recognized the respiratory irritation potential of 
ethylene glycol vapors by setting an exposure limit of 50 ppm 
(125 mg/m3) as a ceiling (15-minute sample). The American 
Conference of Governmental Industrial Hygienists (ACGIH) 





The U.S. Environmental Protection Agency (EPA) has an advisory of 
7 mg/L or 7 ppm ethylene glycol in drinking water.
The Food and Drug Administration (FDA) has approved ethylene 
glycol as a component of adhesives used in packaging.
State Guidelines
Some states have defined acceptable ambient air concentrations for 
ethylene glycol ranging from zero for California to the Texas standard 
of 1.4 ppm (3.9 mg/m3) for 30 minutes. Arizona has a drinking water 
quality guideline of 5,500 |ig/L (5.5 ppm); Connecticut has a drinking 
water quality standard of 100 ng/L (0.1 ppm). Vermont has an 
enforcement standard of 7.0 mg/L (7.0 ppm) for groundwater.
Additional inform ation: The community is worried that the deicing flu id  spilled at the a irport w ill 
contaminate the groundwater supply. They call a town meeting and ask you to speak on the 
health hazards of ethylene glycol and the regulations governing its presence in a ir and water.






FDA classifies propylene glycol as a Generally Recognized as Safe 
(GRAS) additive. Propylene glycol acts as an emulsifying agent, humec- 
tant, surfactant, and solvent in certain medicines, cosmetics, and food 
products. Concentrations in foods range from <0.001% in eggs and 
soups to about 15% in some seasonings and flavorings. The largest 
amounts of propylene glycol are used in the textile industry, where it is 
an intermediate in polyester fiber production. Synonyms for propylene 
glycol include 1,2-propanediol, 1 ,2-dihydroxypropane, methyl glycol, 
and trimethyl glycol.
The military uses aerosolized propylene glycol as a smoke screen on the 
battlefield to conceal the movement of troops. Because it can provide 
dense smoke without flames, it is also a smoke simulator in various types 
of fire-training materials. Propylene glycol is sometimes used as a 
deicing agent; however, ethylene glycol is used more often because it 
costs less. Propylene glycol is an FDA-approved additive for military 
dietary rations.
In the general population, propylene glycol exposure occurs primarily 
through ingestion of food and medications and through dermal contact 
with cosmetics or topical medications. No adverse health effects are 
likely to occur from normal use of these products.
Who’s at Risk
□  Propylene glycol toxicity is 




Absorption of propylene glycol from the gastrointestinal tract is rapid, 
with maximal plasma concentrations in humans occurring within 1 hour 
after ingestion. Propylene glycol is metabolized in the liver by alcohol 
dehydrogenase to lactic acid, then to pyruvic acid. Both of these 
metabolites are normal constituents of the citric acid cycle and are f u rther 
metabolized to carbon dioxide and water. About 45% of an absorbed 
propylene glycol dose is excreted by the kidneys unchanged or as the 
glucuronide conjugate. The elimination half-life of propylene glycol is 
about 4 hours.
□  Propylene glycol is
metabolized to compounds 
that are normal 
constituents of the citric 
acid cycle.
Propylene glycol toxicity has been reported only rarely and in unusual 
circumstances involving medical applications such as intravenous injec­
tion or prolonged dermal contact during treatment of burns. (See 
Physiologic Effects, page 19.)
□  Propylene glycol is used in 






CNS depression is the primary manifestation of acute propylene 
glycol poisoning. Metabolic conversion of propylene glycol to lactic 
and pyruvic acids can contribute to metabolic acidosis with an 
abnormal anion gap. Unchanged propylene glycol circulating in the 
body causes hyperosmolality.
Although propylene glycol is nontoxic under normal conditions, it 
can cause poisoning in rare and unusual circumstances. In one 
case, an 8-month-old infant with large surface area second- and 
third-degree burns was treated for many days with topical silver 
sulfadiazine containing a large amount of propylene glycol. The 
infant developed acute metabolic acidosis and cardiorespiratory 
arrest. The dose of propylene glycol was 9,000 mg/kg/day. Serum 
propylene glycol levels were highest on day 14(1,059 mg/dL) when 
the osmolal gap was 75 mOsm/L (normal: <10 mOsm/L).
Propylene glycol is a common diluent for injectable medications and 
constitutes 40% of the intravenous form of phenytoin. This high 
concentration is necessary to maintain a stable preparation and to 
prevent precipitation of phenytoin crystals. In some patients given 
intravenous phenytoin, propylene glycol was reported to cause 
hypotension, cardiac conduction disturbances, and cardiac 
dysrhythmias; fatal cardiacand respiratory arrests have been reported.
Propylene glycol has not been associated with nephrotoxicity in 
humans. Unlike ethylene glycol, propylene glycol is not metabolized to 
oxalic acid with subsequent deposition of calcium oxalate in the kidneys.
Large doses and unusual 
circumstances are necessary 
for the development of 
propylene glycol toxicity.
Propylene glycol poisoning is 
marked initially by CNS 
depression and an elevated 
osmolal gap, and later by an 
increased anion gap.
Unlike ethylene glycol, 
propylene glycol does not 
produce nephrotoxicity in 
humans.
Clinical Evaluation, Treatment, and Management
Although the toxicity of propylene glycol is low, if large amounts are 
absorbed, an elevated osmolal gap may result. Because propylene 
glycol is metabolized to lactic acid, ingestion of massive doses of 
propylene glycol can cause severe metabolic acidosis. Coma, 
seizures, and hypoglycemia rarely develop in patients with propylene 
glycol intoxication. Cardiac monitoring is needed if other symptoms 
are present.
Metabolic acidosis caused by ingestion of large amounts of propyl­
ene glycol can be corrected with sodium bicarbonate therapy. 
Hemodialysis is effective in correcting hyperosmolality by removing 
propylene glycol from the blood. Ethanol therapy, as described for 
ethylene glycol-poisoned patients, is unnecessary for patients with 
propylene glycol poisoning.
Treatment for propylene glycol 
poisoning is supportive and 
involves hemodialysis and 
correction of metabolic acidosis 
using sodium bicarbonate 
therapy.
Standards and Regulations
There are no workplace or environmental standards for propylene 
glycol. FDA considers an average daily dietary intake of 23 mg/kg of 
body weight to be safe for persons 2 to 65 years of age.
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Sources of Information
More information on the adverse effects of ethylene glycol and propylene glycol and treating cases of exposure 
to these glycols can be obtained from ATSDR, your state and local health departments, and university medical 
centers. Case Studies in Environmental Medicine: Ethylene/Propylene Glycol Toxicity is one of a series. T o obtain 
other publications in this series, please use the order form on the inside back cover. For clinical inquiries, contact 
ATSDR, Division of Health Education, Office of the Director, at (404) 639-6204.
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Answers to Pretest and Challenge Questions
Pretest questions are on page 1. Challenge questions begin on page 3.
Pretest
(a) The man’s problem list includes ataxia, vomiting, agitation, disorientation, hyperventilation, and an elevated 
anion-gap metabolic acidosis. The child’s problem list includes somnolence, ataxia, mental status changes, 
vomiting, hypoglycemia, low body temperature, and an anion-gap metabolic acidosis.
Common toxic agents associated with an elevated anion gap are shown in Table 2 on page 11.
(b) Additional testing of these patients should include urinalysis, complete blood count, serum osmolality measured 
by the freezing-point-depression technique, ethylene glycol and methanol levels, and liver function tests.
(c) Treatment for the 67-year-old man is found in Challenge answer 6 on page 22. Additional information on 
the condition of the child is in Additional Information for Challenge question 7, page 16. Treatment for the 
child is discussed in Challenge answer 7 below.
Challenge
(1) The most common sources in epidemic poisonings include contaminated food, beverages, and water supplies. 
The investigators would inquire about types of food and drink available at the airport. They would take a 
detailed history of food and beverage intake from the patients and all others at the airport, in an attempt 
to find a common factor that would include those who were ill and exclude those who did not become ill. By 
gathering such data from a large number of people and statistically analyzing the data, the exposure source 
can usually be identified or possibilities restricted.
(2) The lethal dose of antifreeze (95% ethylene glycol) is about 100 mL, although there is wide variation among 
reported cases. A cup (240 mL) of the contaminated water would contain about 22 mL of ethylene glycol. This 
dose could cause significant toxicity. Even mild symptoms of ethylene glycol poisoning would be a concern 
for air traffic controllers and other airport personnel responsible for judgments affecting many lives. All 
employees and visitors who consumed beverages or food prepared using water at the airport should be 
examined.
(3) Absorption of ethylene glycol is slow through intact skin. Because the patient showered and changed clothes 
immediately, it is unlikely that he will experience toxic effects from the spill. In the case of chronic exposure 
during the deicing process, few particles from a spraying device are likely to be respirable, so inhalation of 
ethylene glycol would be minimal. Contact during the deicing process would not contribute substantially to 
toxicity, especially if protective clothing and respiratory protection were used. There is no evidence that 
ethylene glycol causes cancer in humans.
(4) You can inform the patient that although no studies in humans specifically assess the effects of ethylene glycol 
on fetal development, no reports in humans suggest adverse outcomes. In addition, studies in experimental 
animals indicate that ethylene glycol does not cause developmental effects.
(5) See Pretest answer (b) above. No test for methanol is necessary if it is established that the water was 
contaminated with ethylene glycol.
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(6) Several hours have passed since the ingestion, and emesis or gastric lavage will be of little value. Activated 
charcoal is likely to be ineffective. However, it is important to act promptly to correct the metabolic acidosis 
and to prevent further conversion of the remaining ethylene glycol to its toxic metabolites. The acidosis can 
be corrected with sodium bicarbonate therapy. Intravenous administration of ethanol as described on page 
14 will inhibit further metabolism of ethylene glycol. At serum ethylene glycol levels of 50 mg/dL or greater, 
hemodialysis should be instituted to remove ethylene glycol and its metabolites from the blood. Pyroxidine 
and thiamine should also be administered.
(7) It is possible that the child is intoxicated with only ethanol or with both ethanol and ethylene glycol. If intoxication 
is due to ethanol alone, careful monitoring of blood glucose and ethanol should be carried out until intoxication 
resolves. However, you must consider that ethylene glycol poisoning may be a complication. Because ethanol 
competitively inhibits ethylene glycol metabolism, you may choose to let the ethanol level decrease naturally 
to 70 mg/dL, then administer ethanol intravenously to maintain that level. The child should be transferred 
immediately to a pediatric unit where hemodialysis can be instituted if laboratory results indicate that ingestion 
of ethylene glycol occurred.
(8) Information about health effects and standards and regulations can be obtained from the Technical Report for 
Ethylene/Propylene Glycol available from the Agency for Toxic Substances and Disease Registry (ATSDR). 
(For the address and telephone number of this agency, see Sources of Information, page 20.) The air and 
water standards vary with each state. A search of EPA’s Hazardous Substance Data Bank may provide 




Continuing education credit is available to health professionals who use this monograph and complete the 
posttest. The criterion for awarding continuing medical education (CME) credits and continuing education units 
(CEU) is a posttest score of 70% or better.
The Centers for Disease Control and Prevention (CDC) is accredited by the Accreditation Council for Continuing 
Medical Education (ACCME) to sponsor continuing medical education for physicians, and by the International 
Association for Continuing Education and Training (I ACET) to sponsor continuing education units for other health 
professionals.
The Agency for Toxic Substances and Disease Registry, in joint sponsorship with CDC, is offering 1 hour of CME 
credit in Category 1 of the Physician's Recognition Award of the American Medical Association and 0.1 hour of 
CEU for other health professionals upon completion of this monograph.
In addition, the series Case Studies in Environmental Medicine has been reviewed and is acceptable for credit 
by the following organizations:
The American Academy of Family Physicians (AAFP). This program has been reviewed and is acceptable for
1 prescribed hour by the American Academy of Family Physicians. (Term of Approval: beginning January 1992.) 
For specific information, please consult the AAFP Office of Continuing Medical Education.
The American College of Emergency Physicians (ACEP). Approved by the American College of Emergency 
Physicians for one hour per issue of ACEP Category I credit.
The American Osteopathic Association (AOA). AOA has approved this issue for 1 credit hour of Category 
2-B credit.
The American Association of Occupational Health Nurses (AAOHN). AAOHN has approved this program for
1.0 contact hours. Applicant will receive the assigned code number in the award letter.
The American Board of Industrial Hygiene (ABIH). ABIH has approved this program for 0.5 certification 
maintenance (CM) point per 3 Case Studies. The CM approval number is 2817.
To receive continuing education credit (CME or CEU), complete the Posttest on page 24 in the manner shown in 
the sample question below. Circle all correct answers.
Which of the following is known to precipitate migraine headaches?





After you have finished the Posttest, please transfer your answers to the answer sheet on the inside back cover 
and complete the evaluation on the lower half of that page. Fold, staple, and mail the inside back cover to 
Continuing Education Coordinator, Agency for Toxic Substances and Disease Registry, Division of Health 
Education, E33, 1600 Clifton Road, Atlanta, GA 30333. Your confidential test score will be returned with an 
indication of where the correct answers can be found in the text. Validation of earned CME credit and CEU will 
also be forwarded to participants, and their names, if requested, will be placed on the mailing list to receive other 




Circle all correct answers. Record your answers on page 25.











e. fluids for closed heating systems
3. Which of the following statements about ethylene glycol are true?
a. Inhalation is a common route of exposure due to the high vapor pressure.
b. Severe skin irritation occurs with minimal contact.
c. Accidental or intentional ingestion accounts for most poisonings.
d. Alcohol abusers may use it as an ethanol substitute.
e. It is absorbed readily through intact skin.
4. The first stage of ethylene glycol poisoning generally includes
a. oliguric renal failure
b. symptoms similar to those of ethanol intoxication
c. cardiopulmonary symptoms such as tachypnea and pulmonary edema
d. nausea and vomiting
e. a characteristic odor of ethanol on the breath
5. Which of the following statement(s) about exposure to ethylene glycol is (are) not true?
a. Air concentrations around toxic waste sites are likely to pose a health threat to nearby residents.
b. Water contaminated by an ethylene glycol spill will remain tainted for years.
c. Ethylene glycol is stored and persists in fatty tissues.
d. Activities such as deicing of planes are likely to result in severe adverse health effects.
e. Ethylene glycol is a significant contributor to urban smog.
6. Which of the following statements comparing ethylene glycol and propylene glycol are true?
a. Given ingestion of equal doses, both glycols result in similar toxicity.
b. Propylene glycol is most commonly found in foods and medicines, and ethylene glycol is found in 
antifreeze and other commercial products.
c. Both glycols are used for aircraft deicing.
d. Neither compound is likely to persist for long periods in the environment.
e. Both compounds are Generally Recognized as Safe (GRAS) by FDA.
7. Useful laboratory tests for diagnosing ethylene glycol poisoning include determinations of
a. arterial blood gases
b. serum creatinine
c. aminotransferases (AST, ALT)
d. serum ferritin
e. serum calcium
8 . Treatment for acute propylene glycol poisoning might include
a. sodium bicarbonate therapy
b. hemodialysis





CASE STUDIES IN ENVIRONMENTAL MEDICINE:ETHYLENE/PROPYLENE GLYCOL TOXICITY
If you wish CME credits or CEU, please indicate your answers to the Posttest questions on page 24 by circling 
the letters below for the correct answers. Complete the evaluation questionnaire and fill in the information 
requested on the reverse side. Tear off this last page, fold, staple, and mail to Continuing Education Coordinator, 
Agency for Toxic Substances and Disease Registry, Division of Health Education, E33,1600 Clifton Road, Atlanta, 
GA 30333.
1 . a b c d e
2 . a b c d e
3. a b c d e
4. a b c d e
5. a b c d e
6. a b c d e
7. a b c d e
8 . a b c d e
Evaluation Questionnaire
Please complete the following evaluation by putting a check in the appropriate box.
, „ Yes No Undecided
1. As a result of completing this monograph, I will be able to:
Explain why ethylene glycol may be an acute and chronic health hazard. □ □ □
Describe the factors contributing to glycol toxicity. □ □ □
Identify potential environmental and occupational sources of 
exposure to glycols. □ □ □
Identify evaluation and treatment protocols for persons 
exposed to glycols. □ □ □
List sources of information on ethylene glycol and propylene glycol. □ □ □
2. I am more likely to ask patients questions regarding possible environmental 
exposures as a result of reading this issue. □ □ □
3. I would recommend this issue to my colleagues. □ □ □
4. I will keep this issue as a reference. □ □ □
Comments:.
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Agency for Toxic Substances and Disease Registry 
Division of Health Education, E33 
1600 Clifton Road, NE 
Atlanta, GA 30333
fold here second
Please send me the following Case Studies in Environmental Medicine.
□ Arsenic a Exposure History □ Radon
a Asbestos □ Gasoline a Risk Communication
□ Benzene a Jet Fuel a Reproductive and
a Beryllium □ Lead Developmental Haza
□ Cadmium □ Mercury □ Skin Lesions
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a Cholinesterase Inhibitors □ Nitrates/Nitrites □ 1 ,1,1 -Trichloroethane
□ Chromium a Pentachlorophenol □ Trichloroethylene
□ Cyanide a Polyaromatic Hydrocarbons (PAHs) □ Toluene
□ Dioxins a Polychlorinated Biphenyls (PCBs) □ Vinyl Chloride
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